Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>S=МИТОКСАНТРОН<.>)
Общее количество найденных документов : 611
Показаны документы с 1 по 20
 1-20    21-40   41-60   61-80   81-100   101-120      
1.
11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone // Amer. J. Hematol., 1996. Vol. 53, N 4.-С.264-266

2.
11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone // Amer. J. Hematol., 1996. Vol. 53, N 4.-С.264-266

3.
11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone // Amer. J. Hematol., 1996. Vol. 53, N 4.-С.264-266

4.
11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone // Amer. J. Hematol., 1996. Vol. 53, N 4.-С.264-266

5.
A dose-intense cyclic treatment (RX) program for adult acute lymphoblastic leukemia (ALL) // Haematologia, 1991. Vol. 76, Suppl. N4.-С.65

6.
A new combination of two intercalating agents (mitoxantrone+daunomycin) in adult refractory acute leukemia: the DON protocol // Cancer Chemother. and Pharmacol., 1988. Vol. 22, N 4.-С.344-346

7.
A Phase I pharmacokinetic study of 21-day continuous infusion mitoxantrone // J. Clin. Oncol., 1989. Vol. 7, N 6.-С.790-797

8.
A phase I-II study of high-dose cyclophosphamide, thiotepa and escalating doses of mitoxantrone with autologous stem cell rescue in patients with refractory malignancies // Bone Marrow Transplant., 1990. Vol. 6, N 6.-С.439-442

9.
A phase II study of mitoxantrone in advanced squamous cell cancer of the head and neck // Invest. New Drugs, 1990. Vol. 8, N 1.-С.109-111

10.
A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer // J. Clin. Oncol., 1990. Vol. 8, N 11.-С.1782-1788

11.
A phase II study of mitozantrone in advanced carcinoma of the ovary // Cancer Chemother. and Pharmacol., 1989. Vol. 24, N 3.-С.200-202

12.
A pilot study of three sequential chemotherapeutic regimens in metastatic breast cancer // Amer. J. Clin. Oncol., 1991. Vol. 14, N 1.-С.45-48

13.
A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma // J. Clin. Oncol., 1988. Vol. 6, N 10.-С.1611-1620

14.
Accidental overdose of mitoxantrone in three patients // Med. Oncol. and Tumor Pharmacother., 1989. Vol. 6, N 4.-С.275-278

15.
Acide folinique, 5-fluorouracile (5 FU) bolus et perfusion continue. Mitoxantrone et cyclophosphamide (C) dans le cancer du sein mteastatique // Bull. Cancer, 1991. Vol. 78, N 6.-С.500

16.
Acute disseminated encephalomyelitis in young adults: Clinical presentation, differential diagnosis and treatment // Arq. neuro-psiquiat., 2009. Vol. 67, прил. 1.-С.41

17.
Acute leukaemias-clinic-morphological characteristics, evolution and treatment // Докл. Бьлг. АН, 1994. Vol. 47, N 9.-С.121-123

18.
Acute leukemia during pregnancy: association with immune-mediated thrombocytopenia in mother and infant // Acta haematol., 1990. Vol. 83, N 3.-С.140-144

19.
Acute myelogenous leukemia in the elderly // J. Amer. Geriatr. Soc., 1992. Vol. 40, N 3.-С.277-284

20.
Acute myeloid leukaemia induced by mitoxantrone. Case report // Arq. neuro-psiquiat., 2005. Vol. 63, N 2.-С.327-329

 1-20    21-40   41-60   61-80   81-100   101-120      
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)